Diatech was founded by John Wilcox, Luis E. Blanco in 1970.

Who are Diatech's investors?

Diatech's investors include Launch Tennessee, TA Associates.

Diatech

Founded 1970 · 788 employees on LinkedIn · 2 known investors

Find your way into Diatech

Paths you didn't know you had: your email and LinkedIn already hold routes to the Diatech team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Diatech Diabetes is a medical device company developing SmartFusion, a software platform and mobile app that monitors insulin infusion pumps for medication delivery failure and measures the accuracy of insulin delivery for people living with diabetes. The technology is in development and its core assets and IP have been acquired by DEKA Research & Development.

Digital Health Healthtech Medical Devices

Founders & leadership

Diatech was founded in 1970 by John Wilcox and Luis E. Blanco.

John Wilcox Co-founder & CEOJohn Wilcox is co-founder and CEO of Diatech Diabetes, a medical device company developing monitoring software for insulin infusion pumps. He has prior experience starting and exiting a medical device company, leading FDA interactions, securing funding from private capital and NIH-NIDDK, and publishing research on diabetes technology in peer-reviewed journals.

Luis E. Blanco Co-founder & CTOLuis E. Blanco is a chemical and biomedical engineer with 8+ years of experience in medical device innovation, microfluidics research, and hardware and software development. He is co-founder and CTO of Diatech Diabetes, which develops SmartFusion, a machine learning-based platform that monitors insulin infusion pumps for delivery failures.

Investors · 2

Launch Tennesseelisted by Launch TennesseeNashville

TA AssociatesreportedBoston

How we know: funding news · Not right? Tell us

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2021	$300K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Diatech do?: Diatech Diabetes is a medical device company developing SmartFusion, a software platform and mobile app that monitors insulin infusion pumps for medication delivery failure and measures the accuracy of insulin delivery for people living with diabetes. The technology is in development and its core assets and IP have been acquired by DEKA Research & Development.
Who founded Diatech?: Diatech was founded by John Wilcox, Luis E. Blanco in 1970.
Who are Diatech's investors?: Diatech's investors include Launch Tennessee, TA Associates.